0001209191-20-036261.txt : 20200612
0001209191-20-036261.hdr.sgml : 20200612
20200612161938
ACCESSION NUMBER: 0001209191-20-036261
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200610
FILED AS OF DATE: 20200612
DATE AS OF CHANGE: 20200612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MERRIFIELD C ANN
CENTRAL INDEX KEY: 0001247224
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36287
FILM NUMBER: 20960441
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Flexion Therapeutics Inc
CENTRAL INDEX KEY: 0001419600
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: (781) 305-7777
MAIL ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-10
0
0001419600
Flexion Therapeutics Inc
FLXN
0001247224
MERRIFIELD C ANN
C/O FLEXION THERAPEUTICS
10 MALL ROAD, SUITE 301
BURLINGTON
MA
01803
1
0
0
0
Common Stock
2020-06-10
4
A
0
4500
0.00
A
14500
D
Stock option (right to buy)
11.88
2020-06-10
4
A
0
7000
0.00
A
2030-06-09
Common Stock
7000
7000
D
Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.
/s/ Mark S. Levine, Attorney-in-Fact
2020-06-12